Table 1 Checklist of criteria for assessing the quality of MRSA prevalence surveys
From: MRSA prevalence in european healthcare settings: a review
Number | Name | Content |
|---|---|---|
1 | Outcome definition | Was a valid definition given of the outcome for prevalence, colonization and infection? |
2 | Time unit | Was the endpoint calculated for a standardized time unit (daily, monthly, yearly)? |
3 | Target population | Was the target population specified by inclusion or eligibility criteria? |
4 | Participants | Was the number of included cases reported, e.g. by describing the numbers and reasons for non-participation? |
5 | Observer bias | Were sources of potential imprecision reported and/or have consequences been discussed? |
6 | Screening procedure | Were measures described that had been undertaken for standardization of screening measurements? |
7 | Swabbing sites | Have routine surveillance cultures included the anterior nares (or nostrils or nose) and the throat? |